Elevated high-density lipoprotein (HDL) levels due to hepatic lipase mutations do not reduce cardiovascular disease risk: Another strike against the HDL dogma

Sergio Fazio, MacRae F. Linton

Research output: Contribution to journal › Editorial › peer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Elevated high-density lipoprotein (HDL) levels due to hepatic lipase mutations do not reduce cardiovascular disease risk: Another strike against the HDL dogma'. Together they form a unique fingerprint.